High Vista Strategies LLC Abb Vie Inc. Transaction History

High Vista Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $231,420 - $272,370	-3,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $233,549 - $288,030	3,000 New	3,000 $277,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $311,185 - $345,940	-3,500 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $36,804 - $49,284	-400 Reduced 10.26%	3,500 $331,000
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $161,208 - $176,778	-1,800 Reduced 31.58%	3,900 $377,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $398,144 - $508,554	5,700	5,700 $507,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.